Pulmonary Toxicity From Granulocyte Colony Stimulating Factor in a Pediatric Patient Undergoing Autologous Stem Cell Harvest

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Sohini Chakraborty ◽  
Mansi Sachdev ◽  
Minakshi Bansal ◽  
Vikas Dua
Keyword(s):  
Stem Cell ◽  
Pediatric Patient ◽  
Pulmonary Toxicity ◽  
Granulocyte Colony Stimulating Factor ◽  
Colony Stimulating Factor ◽  
Cell Harvest ◽  
Stimulating Factor

Platelet Procoagulant Activity During,Peripheral Blood Stem Cell Harvest

1997 ◽  
Vol 3 (2) ◽  
pp. 124-128 ◽  
Author(s):  
Kaoruko Katsura ◽  
Shosaku Nomura ◽  
Gui Lan Xie ◽  
Tetsuji Ohtani ◽  
Tomoko Ishida ◽  
...  
Keyword(s):  
Stem Cell ◽  
Platelet Count ◽  
Peripheral Blood ◽  
Peripheral Blood Stem Cell ◽  
Annexin V ◽  
Blood Stem Cell ◽  
Granulocyte Colony Stimulating Factor ◽  
Colony Stimulating Factor ◽  
Cell Harvest ◽  
Stimulating Factor

We used flow cytometry to measure platelet-derived microparticle levels in plasma obtained from 16 patients during peripheral blood stem cell harvest (PBSC) and in platelet concentrates prepared by apheresis from 10 normal controls. We also studied the binding of an anti-P-selectin antibody and annexin-V to platelets. When all 60 harvests were assessed, we noted a significant difference in microparticle levels between patients with a platelet count >10 x 104/μl and those with a platelet count <10 X 10 4/μl (12.3 ± 4.4 vs. 75 ± 3.9%). In both the first and total harvests, the percentage of platelets and microparticles positive for anti-P-selectin and annexin-V were significantly higher than the normal control levels. These results suggest that patients undergoing mobilization by granulocyte colony-stimulating factor (G-CSF) who have a platelet count >10 X 10 4/μl are at risk of increased procoagulant activity after retransfusion following PBSC harvest. Key Words: Platelet-derived microparticle— Peripheral blood stem cell harvest—Granulocyte colony-stimulating factor.

Sign in / Sign up

Export Citation Format

Share Document